Day: October 18, 2022

AS Nordecon group company Embach Ehitus OÜ and ICO Park OÜ signed a contract for the construction of the Icosagen AS GMP manufacturing facility located in Eerika tee 1, Õssu village, Kambja municipality. The new manufacturing facility is 1,600 m2 in size and composed of two functional parts – laboratories and cell culture rooms are designed to be on the ground floor, and the production unit with clean room conditions for the production of biological drug candidates for clinical trials will be on the second floor. The cost of the works is appr. 4 million euros plus value added tax. The entire building with the cGMP part will be completed in June 2023. Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment....

Hexagon Purus ASA’s third quarter results 2022 will be released on 1 November 2022, 07:00 CET. Morten Holum (CEO) and Dilip Warrier (CFO) will present the results at 08:30 CET and the presentation will be broadcasted live via https://hexagonpurus.kg5.no/. The presentation will be held in English and will be virtual. A recording of the presentation will be made available on www.hexagonpurus.com. For more information: Mathias Meidell, Investor Relations Director, Hexagon Purus ASATelephone: +47 909 82 242 | mathias.meidell@hexagonpurus.com Dilip Warrier, CFO, Hexagon Purus ASA Telephone: +1 949-236-5528 | dilip.warrier@hexagonpurus.com About Hexagon Purus ASA Hexagon Purus, a Hexagon Composites company, enables zero emission mobility for a cleaner energy future. The company is a world leading provider of hydrogen Type 4 high-pressure...

ENDEAVOUR TO ANNOUNCE ITS Q3-2022 RESULTS ON 10 NOVEMBER 2022 London, 18 October 2022 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) will release its Q3-2022 financial results on Thursday 10 November, before the LSE market open. Management will host a conference call and webcast on the same day, Thursday 10 November, at 8:30 am EST/ 1:30 pm GMT to discuss the Company’s financial results. The conference call and webcast are scheduled at: 5:30am in Vancouver 8:30am in Toronto and New York 1:30pm in London 9:30pm in Hong Kong and Perth The webcast can be accessed through the following link: https://edge.media-server.com/mmc/p/h35v7ffw Click here to add a Webcast reminder to your Outlook Calendar. Analysts and investors are also invited to participate and ask questions by registering for the conference call dial-in via the...

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Biomarker data support strong clinical responses from UV1 in combination with pembrolizumab, also in patients considered less likely to respond to monotherapy checkpoint inhibition   Indicates a potential broader applicability of UV1 in combination with anti-PD-1 checkpoint inhibitors Safety profile of UV1 and pembrolizumab combination comparable to pembrolizumab monotherapyOslo, 18 October 2022: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, presented clinical endpoints and biomarker results from patients in the UV1-103 phase I trial, at the 19th International Conference of the Society for Melanoma Research (SMR), being held 17-20 October...

Incap Corporation        Stock exchange release 18 October 2022 at 9:00 a.m. EESTInside information Incap Corporation: Incap increases its revenue and operating profit estimate for 2022 Incap estimates that its revenue, operating profit (EBIT) and adjusted operating profit (EBIT) for 2022 will be significantly higher than in 2021. The increase in the revenue and operating profit estimate is driven by improved visibility related to the customers’ forecasts and the company’s own assessment of the business development. The estimates are given provided that unexpected events impacting Incap’s business environment do not occur, for example, in the availability of components. Previously Incap estimated that its revenue, operating profit (EBIT) and adjusted operating profit (EBIT) for 2022 would be clearly higher than in 2021. Incap’s...

Extends engagements with companies interested in its microbattery’s core-cell performance benefits for existing and new 1 milliampere-hour (mAh) to 100 mAh applications SAN JOSE, California, October 18, 2022 — Ensurge Micropower (OSE: ENSU, and OTCIQ: ENMPY), today announced it shipped Ensurge microbattery unit-cell samples to a strategic partner with whom it has signed a mutually beneficial evaluation agreement. This is the first step in a broader potential engagement with the company, a global leader in battery products and technologies. “Ensurge continues to expand the commercialization paths for our solid-state Lithium microbattery technology,” said Kevin Barber, Ensurge Chief Executive Officer. “This partnership with a preeminent battery supplier further validates the Ensurge value propositions, technology and go-to-market...

UPM-Kymmene Corporation        Stock Exchange Release (Changes board/management/auditors)        18 October 2022 at 09:00 EEST UPM’s President and CEO Jussi Pesonen will retire during 2024 In accordance with the terms of his service contract, UPM’s President and CEO Jussi Pesonen has announced that he will exercise his right to retire from UPM during 2024. “In 2024 I will have served UPM as President and CEO for 20 years and spent a total of 37 years with the company. The announced timetable aims to secure the success of the strategic growth initiatives as well as business performance over the coming few years. However, it is also time to start planning for the next stage,” says Jussi Pesonen. The schedule also allows UPM’s Board of Directors sufficient time for implementing the succession planning process. The service contract of...

Gofore Plc18 October, 2022 at 9 a.m. EETInsider Information Gofore Plc’s Business Review July-September 2022: Gofore’s growth 32%, record high net sales in September – Employee experience significantly improved July-September 2022Net sales grew by 47% and were 31.7 (21.6) million euros. Organic growth of net sales was an especially notable 32%. Net sales increase from private sector customers was 67%, net sales growth from public sector customers was 35%. Net sales from outside of Finland grew by 98%. Record high net sales in September, 14.8 (10.4) million euros. Adjusted EBITA grew by 38% to 3.7 (2.7) million euros. Profitability was weakened due to growth investments from the comparison period and was 11.8% (12.5%). The number of employees grew to a total of 1,126 (814) people, overall capacity standing at 1,243 (876) people. September’s...

AB “Ignitis grupė” (hereinafter – the Group) informs that, pursuant to the Methodology for determining the price caps for electricity transmission, distribution and public supply services (link in Lithuanian), on 17 October 2022 National Energy Regulatory Council (hereinafter – NERC) adopted the resolution on the price caps for electricity distribution services of AB “Energijos skirstymo operatorius” (hereinafter – ESO) for the following regulatory period (hereinafter – the Resolution) (link in Lithuanian). NERC established ESO income level of electricity distribution services for 2023, comprising EUR 395.5 million, which is  65,0 % higher compared to the income level set for year 2022 (EUR 239.7 million). Income level increase was mainly caused by higher natural electricity technological expenses, which have increased due to higher electricity...